- Correction
- Open Access
- Published:
Correction to: Overexpression of apelin in Wharton’ jelly mesenchymal stem cell reverses insulin resistance and promotes pancreatic β cell proliferation in type 2 diabetic rats
Stem Cell Research & Therapy volume 10, Article number: 6 (2019)
The Original Article was published on 07 December 2018
Correction to: Stem Cell Res Ther
https://doi.org/10.1186/s13287-018-1084-x
The original article [1] contained errors in the presentation of Figure 7. These have now been corrected.
Reference
Gao LR, et al. Overexpression of apelin in Wharton’ jelly mesenchymal stem cell reverses insulin resistance and promotes pancreatic β cell proliferation in type 2 diabetic rats. Stem Cell Res Ther. 2018;9:339 https://doi.org/10.1186/s13287-018-1084-x.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Gao, L.R., Zhang, N.K., Zhang, Y. et al. Correction to: Overexpression of apelin in Wharton’ jelly mesenchymal stem cell reverses insulin resistance and promotes pancreatic β cell proliferation in type 2 diabetic rats. Stem Cell Res Ther 10, 6 (2019). https://doi.org/10.1186/s13287-018-1116-6
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1186/s13287-018-1116-6